Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$912M |
| 2 |
Pinduoduo
PDD
|
+$727M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$584M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$501M |
| 5 |
GE Aerospace
GE
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.3B |
| 3 |
Apple
AAPL
|
+$1.26B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$795M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.48% |
| 2 | Financials | 8.47% |
| 3 | Consumer Discretionary | 7.62% |
| 4 | Healthcare | 7.22% |
| 5 | Industrials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
MP Materials
MP
$9.1B
| $2.43M | ﹤0.01% |
170,187
-30,720
| -15% | -$486K |
|
|
RDUS
3702
DELISTED
Radius Recycling
RDUS
| $2.43M | ﹤0.01% |
115,111
-19,048
| -14% | -$448K |
|
3703
America's Car Mart
CRMT
$26.9M
| $2.43M | ﹤0.01% |
38,027
+9,430
| +33% | +$598K |
|
3704
Evolv Technologies
EVLV
$1.1B
| $2.43M | ﹤0.01% |
545,743
+214,529
| +65% | +$927K |
|
3705
Milestone Pharmaceuticals
MIST
$152M
| $2.42M | ﹤0.01% |
1,353,067
| – | – |
|
|
SRG
3706
Seritage Growth Properties
SRG
$136M
| $2.42M | ﹤0.01% |
250,704
+195,277
| +352% | +$1.83M |
|
3707
Franklin US Low Volatility High Dividend Index ETF
LVHD
$624M
| $2.42M | ﹤0.01% |
65,640
+34,243
| +109% | +$1.22M |
|
3708
CALL
Duke Energy
DUK
$97.3B
| $2.42M | ﹤0.01% |
+25,000
| New | +$2.37M |
|
3709
First Trust Energy AlphaDEX Fund
FXN
$368M
| $2.42M | ﹤0.01% |
128,952
+15,626
| +14% | +$264K |
|
3710
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.15B
| $2.41M | ﹤0.01% |
48,294
-174,490
| -78% | -$8.72M |
|
3711
United States Lime & Minerals
USLM
$3.44B
| $2.41M | ﹤0.01% |
40,385
+8,855
| +28% | +$457K |
|
3712
Heritage Insurance Holdings
HRTG
$991M
| $2.41M | ﹤0.01% |
225,993
+214,764
| +1,913% | +$1.51M |
|
3713
PUT
TJX Companies
TJX
$178B
| $2.4M | ﹤0.01% |
23,700
-68,500
| -74% | -$6.64M |
|
3714
Community Health Systems
CYH
$423M
| $2.4M | ﹤0.01% |
686,333
-876,220
| -56% | -$2.96M |
|
3715
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $2.4M | ﹤0.01% |
17,500
-45,000
| -72% | -$6.15M |
|
3716
Blink Charging
BLNK
$87.9M
| $2.4M | ﹤0.01% |
796,696
+290,180
| +57% | +$819K |
|
3717
CryoPort
CYRX
$762M
| $2.39M | ﹤0.01% |
135,296
-51,266
| -27% | -$812K |
|
|
SYRS
3718
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.39M | ﹤0.01% |
446,591
+206,910
| +86% | +$1.43M |
|
3719
Puma Biotechnology
PBYI
$454M
| $2.39M | ﹤0.01% |
450,580
+334,625
| +289% | +$1.8M |
|
3720
iShares U.S. Carbon Transition Readiness Aware Active ETF
LCTU
$1.26B
| $2.38M | ﹤0.01% |
41,503
+33,157
| +397% | +$1.81M |
|
3721
J&J Snack Foods
JJSF
$1.71B
| $2.38M | ﹤0.01% |
16,460
-57,371
| -78% | -$8.67M |
|
3722
Cadre Holdings
CDRE
$1.41B
| $2.38M | ﹤0.01% |
65,722
+1,006
| +2% | +$35K |
|
3723
Perspective Therapeutics
CATX
$342M
| $2.38M | ﹤0.01% |
+199,651
| New | +$1.7M |
|
|
TELL
3724
DELISTED
Tellurian Inc.
TELL
| $2.37M | ﹤0.01% |
3,587,848
+1,127,911
| +46% | +$765K |
|
3725
PUT
AstraZeneca
AZN
$250B
| $2.37M | ﹤0.01% |
17,500
-150,500
| -90% | -$19.9M |
|
Similar funds
Goldman Sachs's Q1 2024 Portfolio in Review
As of Q1 2024, Goldman Sachs held 6,050 positions worth $564B, up 4% from $543B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $23.2B in Q1 2024, closing 529 positions and reducing 2,527 holdings. Its most notable exit was Cooper Companies, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Goldman Sachs opened a new position in State Street SPDR Portfolio Long Term Treasury ETF worth $195M.
- Goldman Sachs's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 6,982,911 shares worth $195M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $912M increase.
- Goldman Sachs's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.45B.
- Goldman Sachs fully exited Cooper Companies in Q1 2024, selling an estimated $173M.
- Goldman Sachs's ten largest holdings make up 19% of its $564B portfolio in Q1 2024.
- Goldman Sachs opened 470 new positions and closed 529 in Q1 2024.
- Goldman Sachs's portfolio value rose 4% quarter-over-quarter to $564B.
Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.